Pharma & Biotech

The fate of Valneva, along with millions in investor capital, hinges on critical developments unfolding in the coming weeks. Behind...

The biotech sector's attention is firmly fixed on Viking Therapeutics as the company prepares for a featured presentation at the...

This week represents a potentially defining moment for Sensei Biotherapeutics as investors await the company's quarterly financial results. Currently trading...

Recent securities filings reveal that BridgeBio Pharma's chief executive has executed substantial share sales during a period of exceptional stock...

Shares of Minerva Neurosciences experienced an unprecedented rally following the announcement of a substantial financing arrangement valued at up to...

The biotechnology sector is witnessing a remarkable performance from PTC Therapeutics, which is demonstrating substantial operational and financial progress. While...

The financial trajectory of Revolution Medicines presents a fascinating case study in biotech investing, where soaring research expenditures and mounting...

Biotechnology firm Xencor has given investors substantial reasons for optimism following a prolonged downturn. The company's latest quarterly report revealed...

Today marks a critical juncture for BioNTech as the German biotech firm unveils its strategic roadmap in New York. Investors...

In an investment landscape captivated by technological transformation, market participants are perpetually searching for the next frontier of expansion. Two...